Scrip
Ziopharm stops enrolment in Phase II sarcoma trial early on positive data
15 October 2009
Malini Guha
Please Login to read the full article.
15 October 2009
Malini Guha
Ziopharm Oncology has stopped enrolment early in a randomised Phase II trial testing its intravenous chemotherapy drug palifosfamide (Zymafos, ZIO-201) in advanced sarcoma on positive interim data. The US company plans to initiate a registration trial, as early as the first half of next year, following...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Poniard plunges after picoplatin fails pivotal lung cancer trial
- Mixed Phase III results for Erbitux in first-line colorectal cancer
- Personalised therapeutic cancer vaccine shows benefit in Phase III lymphoma trial
- Hopes high for Provenge to become first US-approved therapeutic cancer vaccine
COMMENT
Other Informa Comment
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
